Author:
Fei Yuchang,Yu Huan,Wu Yulun,Gong Shanshan
Abstract
Abstract
Background
Ankylosing spondylitis (AS) is one of several disorders known as seronegative spinal arthritis (SpA), the origin of which is unknown. Existing epidemiological data show that inflammatory and immunological factors are important in the development of AS. Previous research on the connection between immunological inflammation and AS, however, has shown inconclusive results.
Methods
To evaluate the causal association between immunological characteristics and AS, a bidirectional, two-sample Mendelian randomization (MR) approach was performed in this study. We investigated the causal connection between 731 immunological feature characteristic cells and AS risk using large, publically available genome-wide association studies.
Results
After FDR correction, two immunophenotypes were found to be significantly associated with AS risk: CD14 − CD16 + monocyte (OR, 0.669; 95% CI, 0.544 ~ 0.823; P = 1.46 × 10−4; PFDR = 0.043), CD33dim HLA DR + CD11b + (OR, 0.589; 95% CI = 0.446 ~ 0.780; P = 2.12 × 10−4; PFDR = 0.043). AS had statistically significant effects on six immune traits: CD8 on HLA DR + CD8 + T cell (OR, 1.029; 95% CI, 1.015 ~ 1.043; P = 4.46 × 10−5; PFDR = 0.014), IgD on IgD + CD24 + B cell (OR, 0.973; 95% CI, 0.960 ~ 0.987; P = 1.2 × 10−4; PFDR = 0.021), IgD on IgD + CD38 − unswitched memory B cell (OR, 0.962; 95% CI, 0.945 ~ 0.980; P = 3.02 × 10−5; PFDR = 0.014), CD8 + natural killer T %lymphocyte (OR, 0.973; 95% CI, 0.959 ~ 0.987; P = 1.92 × 10−4; PFDR = 0.021), CD8 + natural killer T %T cell (OR, 0.973; 95% CI, 0.959 ~ 0.987; P = 1.65 × 10−4; PFDR = 0.021).
Conclusion
Our findings extend genetic research into the intimate link between immune cells and AS, which can help guide future clinical and basic research.
Funder
the Chinese Medicine Research Program of Zhejiang Province
Publisher
Springer Science and Business Media LLC
Reference57 articles.
1. Chen M, Hu X, Wu M, et al. Serum levels of OPG, RANKL, and RANKL/OPG ratio in patients with ankylosing spondylitis: a systematic review and meta-analysis. Immunol Invest. 2019;48(5):490–504.
2. Mahmoudi O, Jamshidi AR, Karami J, et al. Analysis of killer cell immunoglobulin-like receptor genes and their HLA ligands in Iranian patients with ankylosing spondylitis. Iran J Allergy Asthma Immunol. 2016;15(1):27–38.
3. Yang H, Chen Y, Xu W, et al. Epigenetics of ankylosing spondylitis: recent developments. Int J Rheum Dis. 2021;24(4):487–93.
4. Feldtkeller E, Khan MA, van der Heijde D, et al. Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int. 2003;23(2):61–6.
5. Bostan EE, Borman P, Bodur H, et al. Functional disability and quality of life in patients with ankylosing spondylitis. Rheumatol Int. 2003;23(3):121–6.